Army Unit 1266 Influenza Flu Distribution Contract Signed
Increased Profit Realization Potential Due to Sales Growth

[Asia Economy Reporter Jang Hyowon] GTreeBNT announced on the 24th that it has signed a supply contract for influenza vaccines with an army unit. The contracting party is the 1266th Army Unit, and the contract amount is approximately 5.6 billion KRW. This corresponds to 13% of GTreeBNT's recent sales and is scheduled to be supplied through the Public Procurement Service by November.

AstraZeneca vaccines departing from Icheon City GT B&T Logistics Center are arriving at Jungnang-gu Public Health Center in Seoul on the 25th. Photo by Jinhyung Kang aymsdream@

AstraZeneca vaccines departing from Icheon City GT B&T Logistics Center are arriving at Jungnang-gu Public Health Center in Seoul on the 25th. Photo by Jinhyung Kang aymsdream@

View original image

The World Health Organization (WHO) recently expressed concerns that if influenza and measles simultaneously reemerge following the global spread of the COVID-19 virus, the damage could be even greater. In response, the Ministry of Health and Welfare has taken measures against the spread of infectious diseases by expanding the national immunization program (NIP) from the existing trivalent influenza vaccine (two types of A and one type of B), which was effective for prevention, to the quadrivalent influenza vaccine (two types of A and two types of B).


GTreeBNT secured domestic distribution rights for the COVID-19 vaccine earlier this year and has established a warehouse facility equipped with a dedicated cold chain system for COVID-19 vaccines in Icheon, Gyeonggi Province, taking responsibility for nationwide distribution of vaccines such as AstraZeneca's AZD 1222.



A company representative stated, “As the spread of COVID-19 prolongs, the government recommends vaccination to preempt viral diseases and influenza, so we are focusing on the distribution of COVID-19 vaccines as well as other vaccines. While carrying out the distribution of COVID-19 vaccines as announced earlier this year, we expect that the supply of influenza vaccines this time will strengthen profitability through increased sales.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing